Holen Sie sich die Stockscreener-App
8.06
0.12%
0.010
Handel nachbörslich:
8.06
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Prothena Corporation plc Stocks Attracting Dip Buyers2025 Support & Resistance & Accurate Intraday Trade Tips - newsyoung.net
Published on: 2025-08-14 23:29:29 - 선데이타임즈
Prothena’s SWOT analysis: stock outlook shifts amid pipeline changes - Investing.com
Can trapped investors hope for a rebound in Prothena Corporation plcFree Investment Strategy With Low Risk - Newser
What MACD signals say about Prothena Corporation plcForecast Model for Intraday Buy Signals - Newser
How to escape a deep drawdown in Prothena Corporation plcFree Low Risk High Return Opportunities - Newser
Building trade automation scripts for Prothena Corporation plcBreakout Stock Opportunities with Low Drawdown - Newser
Ranking Prothena Corporation plc among high performing stocks via toolsDividend Strategy Summary With 10-Year Outlook - Newser
Volume spikes in Prothena Corporation plc stock – what they meanFree Safe Entry Stock Watch Suggestions - Newser
How Prothena Corporation plc stock performs during market volatilityLow Exposure Strategy with Sector Analysis - Newser
Trend Reversal Possible in Prothena Corporation plc Charts IndicateSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy - BioSpace
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful - Investing.com India
Prothena (PRTA) Surges on Novo Nordisk's Phase 3 Plans for ATTR Amyloidosis Drug - GuruFocus
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk - TipRanks
Prothena Announces that Novo Nordisk Will Advance Coramitug (For - GuruFocus
Breakthrough: Novo Nordisk Takes Prothena's ATTR Drug to Final Trial Stage with $1.2B Milestone Potential - Stock Titan
Prothena stock price target lowered to $10 at RBC on program discontinuation By Investing.com - Investing.com South Africa
Prothena stock price target lowered to $10 at RBC on program discontinuation - Investing.com Nigeria
PRTA: RBC Capital Maintains Rating, Lowers Price Target | PRTA S - GuruFocus
9 Analysts Assess Prothena Corp: What You Need To Know - 富途牛牛
Prothena’s Losses Grow As Revenue Drops And Programs Wind Down - Finimize
RBC Cuts Price Target on Prothena to $10 From $18, Keeps Sector Perform, Speculative Risk - MarketScreener
Prothena Corp (PRTA) Maintains 'Buy' Rating with $18 Target by C - GuruFocus
JMP reiterates Market Outperform rating on Prothena stock ahead of key data - Investing.com Nigeria
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights - BioSpace
Prothena Reports Q2 2025 Financial Results and Pipeline Progress - TipRanks
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Prothena Corporation PLC reports results for the quarter ended June 30Earnings Summary - TradingView
Prothena Corp PLC Reports Q2 2025 Earnings: EPS Loss of $2.34, Revenue at $4.4 Million, Both Missing Estimates - GuruFocus
Published on: 2025-08-04 19:53:20 - beatles.ru
How does Prothena Corporation plc generate profit in a changing economyAchieve triple-digit returns with smart investing - Jammu Links News
What is the risk reward ratio of investing in Prothena Corporation plc stockMaster stock selection with insider knowledge - Jammu Links News
How strong is Prothena Corporation plc company’s balance sheetInvest smarter with daily stock recommendations - Jammu Links News
What is Prothena Corporation plc company’s growth strategyCapitalize on market shifts with expert advice - Jammu Links News
What catalysts could drive Prothena Corporation plc stock higher in 2025Accelerate your capital gains today - Jammu Links News
Prothena Corporation plc Stock Analysis and ForecastBuild a portfolio that outperforms consistently - Jammu Links News
What are the latest earnings results for Prothena Corporation plcDiscover high-impact stocks for your portfolio - Jammu Links News
Is This a Bottoming Phase for Prothena Corporation plcLow Drawdown Real Time Trading Tips Shared - beatles.ru
Key resistance and support levels for Prothena Corporation plcRisk-Managed Strategy Based on Price Analysis - Newser
Tools to assess Prothena Corporation plc’s risk profileMarket Opportunity Tracker for Swing Traders - Newser
How volatile is Prothena Corporation plc stock compared to the marketEntry Signal Planner To Watch Now - jammulinksnews.com
Intraday pattern recognizer results for Prothena Corporation plcFree Fast Entry High Potential Stock Alerts - Newser
How many analysts rate Prothena Corporation plc as a “Buy”Pre Market Recommendation With Low Risk - Jammu Links News
Can technical indicators confirm Prothena Corporation plc’s reversalCommunity Picked Stocks with Trade Insights - Newser
Prothena Secures Leadership with New Executive Agreements - The Globe and Mail
0.11%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):